Elimination of Albumin-Bound Substances by MARS and Prometheus

计划入组 10 人 · 首次发布于 2006 年 12 月 4 日

Prometheus: Prophylactic Mesh After OLtx for Hernia Reduction Study.

计划入组 100 人 · 首次发布于 2026 年 8 月 4 日

European Pathology Laboratories and COVID-19

计划入组 71 人 · 首次发布于 2020 年 7 月 20 日

1401(Sigmapharm Laboratories)

corticosteroid (Auriga Laboratories)

1403(Sigmapharm Laboratories)

PROMETHEUS LABORATORIES INC.

United States

Prometheus Biosciences, Inc.

United States

Abbott Laboratories

United States

Prometheus Laboratories Advances Next-Generation Blood Test for MASH Patient Identification

Prometheus Laboratories Unveils Groundbreaking Pre-Therapy Test for IBD Biologic Response Prediction

Prometheus Laboratories Expands Precision-Guided Dosing Platform with New Tests for IBD Biologics